Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1587-1592

  Ponthan, Frida ^a   Lindskog, Magnus ^a   Karnehed, Nina ^a   Castro, Juan ^a   Kogner, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

4 HPR; Apoptosis; Fenretinide; Neuroblastoma; Nude rat; Retinoic acid; Treatment; Vitamin A

Indexed keywords

ANTINEOPLASTIC AGENT; FENRETINIDE;

ANIMAL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL CYCLE; EXPERIMENTAL NEOPLASM; HUMAN; MALE; NEUROBLASTOMA; NUDE RAT; ORAL DRUG ADMINISTRATION; RAT; TIME; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; FENRETINIDE; HUMANS; MALE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEUROBLASTOMA; RATS; RATS, NUDE; TIME FACTORS;

EID: 2142743305     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1587     Document Type: Article

References (34)

1. Sidell N: Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68: 589-596, 1982.
2. Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB and Seeger RC: Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res 366: 203-211, 1991.
3. Abemayor E: The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells. Laryngoscope 102: 1133-1149, 1992.
4. Redfern CP, Lovat PE, Malcolm AJ and Pearson AD: Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur J Cancer 4: 486-494, 1995.
5. Lovat PE, Irving H, Annicchiarico-Petruzzelli M, Bernassola F, Malcolm AJ, Pearson AD, Melino G and Redfern CP: Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout. J Natl Cancer Inst 89: 446-452, 1997. (Pubitemid 27136737)
6. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB and Reynolds CP: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341: 1165-1173, 1999. (Pubitemid 29480654)
7. Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Formelli F, Menard S, Costa A, Veronesi U, et al: N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 53: 6036-6041, 1993.
8. Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S and Mabry M: Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J Natl Cancer Inst 87: 1674-1680, 1995.
9. Di Vinci A, Geido E, Infusini E and Giaretti W: Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. Int J Cancer 59: 422-426, 1994. (Pubitemid 24331837)
10. Mariotti A, Marcora E, Bunone G, Costa A, Veronesi U, Pierotti MA and Della Valle G: N-(4-hydroxyphenyl) retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J Natl Cancer Inst 86: 1245-1247, 1994. (Pubitemid 24253701)
11. Dowlatshahi K, Mehta RG, Thomas CF, Dinger NM and Moon RC: Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer. Cancer Lett 47: 187-192, 1989. (Pubitemid 19244842)
12. Pienta KJ, Nguyen NM and Lehr JE: Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res 53: 224-226, 1993. (Pubitemid 23031826)
13. Formelli F and Cleris L: Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. Cancer Res 53: 5374-5376, 1993. (Pubitemid 23342152)
14. Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC and Reynolds CP: Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl) retinamide in neuroblastoma cell lines. J Natl Cancer Inst 91: 1138-1146, 1999. (Pubitemid 29330552)
15. Lovat PE, Ranalli M, Bernassola F, Tilby M, Malcolm AJ, Pearson AD, Piacentini M, Melino G and Redfern CP: Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs. Int J Cancer 88: 977-985, 2000.
16. Reynolds CP, Wang Y, Melton LJ, Einhorn PA, Slamon DJ and Maurer BJ: Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide. Med Pediatr Oncol 35: 597-602, 2000.
17. Biedler JL, Helson L and Spengler BA: Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652, 1973.
18. Nilsson S, Pahlman S, Arnberg H, Letocha H and Westlin JE: Characterization and uptake of radiolabeled metaiodobenzylguanidine (MIBG) in a human neuroblastoma heterotransplant model in athymic rats. Acta Oncol 32: 887-891, 1993. (Pubitemid 24059903)
19. Wassberg E, Pahlman S, Westlin JE and Christofferson R: The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr Res 41: 327-333, 1997. (Pubitemid 27097897)
20. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
21. Castro J, Heiden T, Wang N and Tribukait B: Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 14: 793-804, 1993. (Pubitemid 23290361)
22. Heiden T, Castanos-Velez E, Andersson LC and Biberfeld P: Combined analysis of DNA ploidy, proliferation, and apoptosis in paraffin-embedded cell material by flow cytometry. Lab Invest 80: 1207-1213, 2000. (Pubitemid 30637060)
23. Lasorella A, Iavarone A and Israel MA: Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res 55: 4711-4716, 1995.
24. Reynolds CP and Lemons RS: Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 15: 867-910, 2001. (Pubitemid 34026975)
25. Borgstrom P, Hassan M, Wassberg E, Refai E, Jonsson C, Larsson SA, Jacobsson H and Kogner P: The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo. Pediatr Res 46: 328-332, 1999. (Pubitemid 29400579)
26. Jorgensen GE, Johnsen JI, Ponthan F, Kogner P, Flaegstad T and Traavik T: Human Polyomavirus BK (BKV) and neuroblastoma: mechanisms of oncogenic action and possible strategy for novel treatment. Med Pediatr Oncol 35: 593-596, 2000.
27. Ponthan F, Borgstrom P, Hassan M, Wassberg E, Redfem CP and Kogner P: The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Med Pediatr Oncol 36: 127-131, 2001.
28. Ponthan F, Kogner P, Bjellerup P, Klevenvall L and Hassan M: Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat. Br J Cancer 85: 2004-2009, 2001. (Pubitemid 34775340)
29. Freireich EJ, Gehan EA, Rall DP, Schmidt LH and Skipper HE: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep 50: 219-245, 1966.
30. Veronesi U, De Palo G, Marubini E, Costa A, Formelli F, Mariani L, Decensi A, Camerini T, Del Turco MR, Di Mauro MG, Muraca MG, Del Vecchio M, Pinto C, D'Aiuto G, Boni C, Campa T, Magni A, Miceli R, Perloff M, Malone WF and Sporn MB: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst 91: 1847-1856, 1999.
31. Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, Walsh GL, Broxson A, Lippman SM, Ro JY, Kemp BL, Liu D, Fritsche HA, Xu X, Lotan R and Hong WK: N-(4-hydroxyphenyl) retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 6: 2973-2979, 2000. (Pubitemid 30637717)
32. Thaller C, Shalev M, Frolov A, Eichele G, Thompson TC, Williams RH, Dillioglugil O and Kadmon D: Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration. J Clin Oncol 18: 3804-3808, 2000.
33. Follen M, Atkinson EN, Schottenfeld D, Malpica A, West L, Lippman S, Zou C, Hittelman WN, Lotan R and Hong WK: A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res 7: 3356-3365, 2001. (Pubitemid 33069966)
34. Formelli F: Correspondence re: M. Follen et al, a randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res 8: 1310-1312; discussion 1313, 2002.